Tairui Pharmaceutical Co., Ltd.(Tairui Pharma below) is an export-oriented national key high-tech enterprise with AAA credit rating,owning a State-level Enterprise Technical Center and Engineering Laboratory, nearly 3,500 employees, area coverage of over 400 hectares and total assets of nearly RMB5 billion. Tairui Pharma is mainly engaged in R&D, production and marketing of veterinary APIs and formulations. Leading products include Tylosin (Base/Tartrate/ Phosphate), Tilmicosin(phosphate) and Tiamulin Fumarate. Tairui Pharma is proud to delcare itself as the largest producer of Tylosin in the world. ?Tairui? has been titled as China Famous Brand in 2010. Over 70% of its products have been exported to more than 80 countries and areas worldwide. Since 2011?Tairui entered a new area by starting the production of Erythromycin Thiocyanate with 1000mt annual capacity at its current site and 3000mt capacity at its subsidiary-Ningxia Taipingyang Bio-tech Co., Ltd. All facilities can meet the requirements of current GMP guidelines and have been successfully approved by customers from the Netherlands, Germany, Switzerland, Australia, India, etc.